CorMedix (CRMD) Depreciation & Amortization (CF) (2010 - 2025)

CorMedix has disclosed Depreciation & Amortization (CF) across 15 years of filings, most recently posting $294096.0 for Q4 2025.

• Depreciation & Amortization (CF) for Q4 2025 came in at $294096.0, up 259.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $677000.0 (up 339.61% YoY), and the FY2025 annual result was $677000.0, up 339.61% from the prior year.
• Depreciation & Amortization (CF) came in at $294096.0 for Q4 2025 at CorMedix, up from $161917.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $294096.0 in Q4 2025 to a low of $11994.0 in Q1 2021.
• The 5-year median for Depreciation & Amortization (CF) is $20925.0 (2022), against an average of $52413.2.
• Across the five-year window, Depreciation & Amortization (CF) sank 75.15% in 2021 and jumped 535.97% in 2025, its largest moves.
• CorMedix's Depreciation & Amortization (CF) stood at $20047.0 in 2021, then gained by 12.32% to $22516.0 in 2022, then decreased by 17.08% to $18670.0 in 2023, then soared by 338.08% to $81790.0 in 2024, then surged by 259.57% to $294096.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $294096.0 (Q4 2025), $161917.0 (Q3 2025), and $110993.0 (Q2 2025), per Business Quant data.